Trial intelligence / Profile preview

Intravenous ibuprofen versus ketorolac for renal colic pain

IRCT20230726058930N1Phase 3Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Sep 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of ibuprofen and ketorolac in Renal colic (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Pain intensity, Pain at 0 minutes and 3 more. Started Sep 2023; status: completed.

02

Drugs

ibuprofenketorolac
03

Conditions

Renal colic

Beyond the preview

Go deeper on IRCT20230726058930N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20230726058930N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call